This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Wang, Guangdi
Item Type | Name |
Academic Article
|
Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.
|
Academic Article
|
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD).
|
Academic Article
|
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator.
|
Academic Article
|
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models.
|
Academic Article
|
GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models.
|
Concept
|
Estrogen Antagonists
|
Concept
|
Estrogens
|
Concept
|
Receptors, Estrogen
|
Concept
|
Selective Estrogen Receptor Modulators
|
Concept
|
Estrogen Receptor alpha
|
Academic Article
|
Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.
|
Academic Article
|
Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.
|
Academic Article
|
GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancer.
|
Academic Article
|
Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer.
|
Academic Article
|
Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms.
|
Academic Article
|
From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target.
|
Academic Article
|
Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents.
|
Academic Article
|
Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD).
|